CT-guided permanent 125I seed interstitial brachytherapy for recurrent retroperitoneal lymph node metastases after external beam radiotherapy

Brachytherapy

Volumn 14, Issue 5, 2015, Pages 662-669

  Yao, Lihong ^a   Jiang, Yuliang ^a   Jiang, Ping ^a   Wang, Hao ^a   Meng, Na ^a   Qu, Ang ^a   Tian, Suqing ^a   Sun, Haitao ^a   Liu, Chen ^a   Wang, Junjie ^a   Zhang, Kaixian ^b  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b Tengzhou Central People s Hospital   (China)

Author keywords

125I seed; Interstitial brachytherapy; Re irradiation; Recurrence; Retroperitoneal lymph node

Indexed keywords

IODINE 125; RADIOACTIVE SEED; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER PAIN; CANCER PATIENT; CANCER RECURRENCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISTANT METASTASIS; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; FEASIBILITY STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PAIN ASSESSMENT; PARAAORTIC LYMPH NODE; PATIENT SAFETY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT PLANNING; ADVERSE EFFECTS; COMPLICATION; EVALUATION STUDY; INTERVENTIONAL RADIOLOGY; LYMPHATIC METASTASIS; MIDDLE AGED; PAIN; PROCEDURES; RADIOTHERAPY DOSAGE; RETROPERITONEUM; TUMOR RECURRENCE;

ADULT; AGED; BRACHYTHERAPY; FEASIBILITY STUDIES; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PAIN; RADIOLOGY, INTERVENTIONAL; RADIOTHERAPY DOSAGE; RETROPERITONEAL SPACE; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84940447092     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2015.05.008     Document Type: Article

References (35)

1. Berman M.L., Keys H., Creasman W., et al. Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). Gynecol Oncol 1984, 19:8-16.
2. Tree A.C., Khoo V.S., Eeles R.A., et al. Stereotactic body radiotherapy for oligometastases. Lancet Oncol 2013, 14:e28-37.
3. Hanna G.G., Landau D. Stereotactic body radiotherapy for oligometastatic disease. Clin Oncol (R Coll Radiol) 2015, 27:290-297.
4. Wang J.J., Yuan H.S., Li J.N., et al. Interstitial permanent implantation of 125I seeds as salvage therapy for re-recurrent rectal carcinoma. Int J Colorectal Dis 2009, 24:391-399.
5. Wang J.J., Yuan H.S., Li J.N., et al. CT-guided radioactive seed implantation for recurrent rectal carcinoma after multiple therapy. Med Oncol 2010, 27:421-429.
6. Jiang Y.L., Meng N., Wang J.J., et al. Percutaneous computed tomography/ultrasonography-guided permanent iodine-125 implantation as salvage therapy for recurrent squamous cell cancers of head and neck. Cancer Biol Ther 2010, 9:959-966.
7. Gao F., Li C., Gu Y., et al. CT-guided 125I brachytherapy for mediastinal metastatic lymph nodes recurrence from esophageal carcinoma: Effectiveness and safety in 16 patients. Eur J Radiol 2013, 82:e70-e75.
8. Zhu L., Jiang Y., Wang J., et al. An investigation of 125I seed permanent implantation for recurrent carcinoma in the head and neck after surgery and external beam radiotherapy. World J Surg Oncol 2013, 11:60.
9. Lin L., Wang J., Jiang Y., et al. Interstitial 125I seed implantation for cervical lymph node recurrence after multimodal treatment of thoracic esophageal squamous cell carcinoma. Technol Cancer Res Treat 2015, 14:201-207.
10. Wang H., Wang J., Jiang Y., et al. The investigation of 125I seed implantation as a salvage modality for unresectable pancreatic carcinoma. J Exp Clin Cancer Res 2013, 32:106.
11. Wang Z., Lu J., Gong J., et al. CT-guided radioactive 125I seed implantation therapy of symptomatic retroperitoneal lymph node metastases. Cardiovasc Intervent Radiol 2014, 37:125-131.
12. Cao Q., Wang H., Meng N., et al. CT-guidance interstitial 125 Iodine seed brachytherapy as a salvage therapy for recurrent spinal primary tumors. Radiat Oncol 2014, 9:301.
13. Wernicke A.G., Shamis M., Yan W., et al. Role of isotope selection in long-term outcomes in patients with intermediate-risk prostate cancer treated with a combination of external beam radiotherapy and low-dose-rate interstitial brachytherapy. Urology 2012, 79:1098-1104.
14. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the international association for the study of pain subcommittee on taxonomy. Pain Suppl 1986, 3:S1-S1226.
15. Eisenhauer E.A., Therasse P., Bogaerts J., et al. New response evaluation criteria in solid tumors: Revised RECIST guideline (version 1.1). Eur J Cancer 2009, 45:228-247.
16. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995, 31:1341-1346.
17. Goff B.A., Muntz H.G., Paley P.J., et al. Impact of surgical staging in women with locally advanced cervical cancer. Gynecol Oncol 1999, 74:436-442.
18. Eifel P.J., Morris M., Wharton J.T., Oswald M.J. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1994, 29:9-16.
19. Stehman F.B., Bundy B.N., DiSaia P.J., et al. Carcinoma of the cervix treated with radiation therapy: A multivariate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 1991, 67:2776-2785.
20. Tseng J.Y., Yen M.S., Twu N.F., et al. Prognostic nomogram for overall survival in stage IIB-IVA cervical cancer patients treated with concurrent chemoradiotherapy. Am J Obstet Gynecol 2010, 202:e1-7.
21. Nag S., Beyer D., Friedland J., et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 1999, 44:789-799.
22. Langley S.E., Laing R. Prostate brachytherapy has come of age: A review of the technique and results. BJU Int 2002, 89:241-249.
23. Zhang F.J., Li C.X., Zhang L., et al. Short-to mid-term evaluation of CT guided 125I brachytherapy on intra-hepatic recurrent tumors and/or extra-hepatic metastases after liver transplantation for hepatocellular carcinoma. Cancer Biol Ther 2009, 8:585-590.
24. Blasko J.C., Mate T., Sylvester J.E., et al. Brachytherapy for carcinoma of the prostate: Techniques, patients selection and clinical outcome. Semin Radiat Oncol 2002, 12:81-94.
25. Monk B.J., Tewari K.S., Puthawala A.A., et al. Treatment of recurrent gynecologic malignancies with iodine-125 permanent interstitial irradiation. Int J Radiat Oncol Biol Phys 2002, 52(3):806-815.
26. Rivard M.J. Comment on "Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group 43" (Med Phys 22, 209-234(1995)). American Association of Physicists in Medicine. Med Phys 1999, 26:2514.
27. Jones D., Washington J.T., Christopherson D.A. Comments on "Dosimetry of interstitial brachytherapy source: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43" (Med Phys 22, 209-234(1995)). Med Phys 1995, 22:1349-1351.
28. Jiang Y., Huang Z.L., Wu P.H., et al. Short-term efficacy of ct-guided radioactive seed 125I implantation on residual or relapsing metastatic lymph nodes in advanced tumor patients after multi-modality treatment. Ai Zheng 2008, 27:1082-1087.
29. Gao F., Gu Y.K., Huang J.H., et al. Clinical value of CT-guided (125)I brachytherapy for retroperitoneal metastatic lymph node from PHC. Zhonghua Yi Xue Za Zhi 2013, 93:2155-2157.
30. Jereczek-Fossa B.A., Fariselli L., Beltramo G., et al. Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer. Radiother Oncol 2009, 93:14-17.
31. Milano M.T., Katz A.W., Zhang H., Okunieff P. Oligometastases treated with stereotactic body radiotherapy: Long-term follow-up of prospective study. Int J Radiat Oncol Biol Phys 2012, 83:878-886.
32. Jereczek-Fossa B.A., Beltramo G., Fariselli L., et al. Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer. Int J Radiat Oncol Biol Phys 2012, 82:889-897.
33. Ponti E., Ingrosso G., Carosi A., et al. Salvage stereotactic body radiotherapy for patients with prostate cancer with isolated lymph node metastasis: A single-center experience. Clin Genitourin Cancer 2014, pii: S1558-7673(14)00288-2. 10.1016/j.clgc.2014.12.014.
34. Decaestecker K., De Meerleer G., Lambert B., et al. Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence. Radiat Oncol 2014, 9:135.
35. Seo Y.S., Kim M.S., Cho C.K., et al. Stereotactic body radiotherapy for oligometastases confined to the para-aortic region: Clinical outcomes and the significance of radiotherapy field and dose. Cancer Invest 2015, 33:180-187.